Nanocarriers in Neurodegenerative Disorders

Therapeutic Hopes and Hypes
1. Auflage 2024
ISBN: 978-1-032-46795-5
Verlag: Taylor & Francis

Buch, Englisch, 366 Seiten, Format (B × H): 210 mm x 280 mm, Gewicht: 1280 g

Due to the lack of secure, efficient, and patient-friendly therapies for neurodegenerative disorders, there is a rising demand for innovative approaches. Despite the limited number of nanocarriers approved for human use, they have demonstrated significant potential in preclinical and, in some instances, clinical trials. In alignment with this objective, the chapters of the book are structured to offer a comprehensive overview of recent advancements in medication and dosage form development, specifically emphasizing the nanoparticulate system for targeting the brain. This book aims to furnish readers with a thorough understanding of the clinical application of nanocarrier systems for treating neurodegenerative disorders, encompassing the latest developments, challenges, safety concerns, toxicity issues, regulatory considerations, prospects, and limitations. Individuals in academia, the scientific community, business, and education seeking a more effective approach to target the brain will find valuable insights in this resource.

Key Features

- Provides a comparative perspective of various nanocarrier systems, therefore facilitating the researcher's selection of appropriate nanoparticulate carriers

- Highlights the related restrictions of brain delivery and current available medicines

- Includes information on the advantages and disadvantages of various biomaterials utilized in the development of nanocarriers for brain targeting

- Emphasizes distinct facets of surface functionalization according to the brain area of interest

- Presents the current advances, preclinical and clinical development, and the future potential of multiple brain-targeting technologies

Zielgruppe

Academic, Postgraduate, and Professional Reference

Autoren/Hrsg.

Mohamed, Wael

Fachgebiete

• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Biotechnologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
• Technische Wissenschaften Technik Allgemein Nanotechnologie
• Interdisziplinäres Wissenschaften Wissenschaften Interdisziplinär Neurowissenschaften, Kognitionswissenschaft
• Naturwissenschaften Biowissenschaften Angewandte Biologie Biophysik
• Naturwissenschaften Biowissenschaften Biowissenschaften
• Naturwissenschaften Biowissenschaften Zellbiologie
• Naturwissenschaften Biowissenschaften Molekularbiologie

Inhaltsverzeichnis

SECTION-I: NANOMEDICINE IN NEURODEGENERATIVE DISORDERS

Ch1 - Fundamentals of Brain–Barrier Anatomy and Global Functions

Yasser Mecheri, Soundous Malak Behloul

Ch2 - Blood Brain Barrier in Neurodegenrative Disorders

Adejoke Elizabeth Memudu, Michael Oluwatosin Gabriel

Ch3 - Neurodegenerative Disorders, available therapies, and their limitations

Mohamed Zaki, Eman E. Mohamed, Osama M. Ahmed

Ch4 - Challenges in brain targeting and mechanism of drug transfer across BBB

Ahmad Kodous, Priya Ramanathan, Arunagiri Kuha Deva Magendhra Rao, Gamal Abdel Nasser Atia

Ch5 - Introduction to Nanomedicine, Nanotechnology and Nanopharmaceuticals

Abdullah M. M. Elbadry, Hend H. Mohamed

Ch6 - Regulations and Ethics of Nanomedicine and Public acceptance

Nada Abdel-Monaem

Ch7 - Safety of Nanoparticles in Medicine

Mona Mohammed Abd elHakeem khalifa

Ch8 - Enhancing Brain Drug Delivery with Lipid Nanocarriers for Bioactive Compounds

Shivakumar M Methri, Sivakumar Manickam, V. Ravichandiran, Subramanian Natesan

Ch9 - Blood brain Barrier disruption and Nanomedicine in Neurodegenerative disorders

Adejoke Elizabeth Memudu, Michael Oluwatosin Gabriel, Grace Temitope Akingbade, Happiness Ochi Inyang, Omamuyovwi Meashack Ijomone

Ch10 - Worldwide Development and Commercialization of Nanomedicine

Hadeer N. Atalah, Esraa M. Qansuwa

SECTION-II: NANOPARTICLES AND NEURODEGENERATIVE DISORDERS

Ch11 - Introduction to nanoparticles as a potential carrier for brain targeting in Neurodegenerative Disorders

Adejoke Elizabeth Memudu, Michael Oluwatosin Gabriel, Victor Ebube Anadu, Olayemi Kafilat Ijomone, Omamuyovwi Meashack Ijomone

Ch12 - Application of polymeric nanoparticles in brain targeting  Moshera Samy

Ch13 - Lipid-based Nanocarriers for Brain Delivery of Bio-actives in the Treatment of Neurodegenerative Disorders

Khaled M. Kotb, Mohamed N. Sharafeldin, Hamsa Hassan, Achouak BOUTALBI, Ahmed Yahya, Haseen Fatima Niazi, Nouran A. Taha, Islam Omar, Amgad E. Salem

Ch14 - Autophagy and extracellular nanovesicles communication and their therapeutic application in neurodegenerative diseases.

Mohamed Abdelkader, Noha AboQuella

Ch15 - Mesoporous silica nanoparticles as promising carriers for brain delivery

Sudarshan Naidu Chilamakuri, Sivakumar Manickam, Rajukumar Malayandi Ravichandiran Velayutham, Subramanian Natesan

Ch16 - Potential of dendrimers as a nanocarrier for brain drug delivery

Arab Iram Saba Gaus Mohammed, Victor Hmingthansanga, Sivakumar Manickam, V. Ravichandiran, Subramanian Natesan

Ch17 - Surface active ligands for brain targeting

Mariam Zewail, Heba Abd-El-Azim

Ch18 - Nanocarriers for brain delivery: Safety, Stability concerns, and regulatory aspects

Asmaa Ashraf, Mohamed Dahab, Rahma Soliman

Ch19 - Advancements of nanocarriers for brain targeting and limitations in clinical translation

Nermeen Z. Abuelezz, Fayza Eid Nasr, María-Salud García-Ayllón, Javier Sáez-Valero

Ch20 - Toward Applicability of Exosomal-ncRNA Precision vs Nanoparticles to the Brain

Nadia M. Hamdy, Emad B. Basalious, Mona G. El-Sisi, Rana A. Youness, Ahmed S. Sultan

Ch21 - Current advancements of nanocarriers for neurodegenerative disorders linked to toxoplasmosis

Mohamed Y. Zaky, Nahed S. Lamloum

Ch22 - Toward Nano-drugs Precision for Neurodegenerative disease(s) or Glioma

Nadia M. Hamdy, Emad B. Basalious, Al-Aliaa Sallam, Fatma H. Shaker, Sujay Paul, Shih-Min Hsia, Mai M. Anwar

Über Autor(innen)

Dr. Wael Mohamed Yousef Mohamed, a Physician Neuroscientist, earned his PhD from PSU in the USA and currently holds the position of Associate Professor at IIUM Medical School in Malaysia. With an extensive background, Dr. Mohamed has been invited to deliver over 150 lectures both domestically and internationally. His contributions to Neuroscience/Psychiatry are notable, with the publication of more than 100 peer-reviewed papers, boasting an h-index of 20. Furthermore, Dr. Mohamed serves as an editor for Frontiers in Neurology and PLOS-ONE Journals, where he has contributed to various journal special issues on brain disorders. In the realm of book editing, he is actively involved with Springer, CRC, and Cambridge in the field of neuroscience. His research endeavors have attracted numerous grants from esteemed national and international organizations, including IBRO, ISN, MJF, STDF, FRGS, and INDO-ASEAN, amounting to a total research funding of half a million US$. Notably, he is the founder and chair of the AfrAbia-PD-Genomic Consortium.